Physician profile
Jeff S Silber
NPI 1790864999
$130,459.55
in general payments reported to CMS, 2019-2025
8 companies · $8,152 in 2025
The $8,152 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $21K · 2021: $27K · 2022: $17K · 2023: $9,074 · 2024: $13K · 2025: $8,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Food and Beverage: $633 · Travel and Lodging: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $29,250.00 |
| Food and Beverage | $632.95 |
| Travel and Lodging | $597.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $105,983.11 | 2019-2025 | Everest Spinal System, Mesa Spinal System, Serrato |
| Medtronic USA, INC. | $16,202.17 | 2019 | |
| Vb Spine LLC | $7,800.00 | 2025 | Capri Corpectomy Cage System, Everest Spinal System |
| Djo, LLC | $142.85 | 2019 | |
| Orthofix Medical, INC. | $135.22 | 2024 | Spinal-Stim |
| Biocomposites INC | $120.00 | 2024 | |
| Depuy Synthes Sales INC. | $49.97 | 2023-2025 | Orthovisc, Velys |
| Medtronic, INC. | $26.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Silber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.